MedTrace Logo

Are Rehabilitation Results in Flexor Tendon Zone II Injuries as Bad as Feared?

NCT06112145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2024-05-08

No results posted yet for this study

Summary

The hand is the basic functional organ of the human body and is responsible for complex tasks such as grasping and catching. It also plays an important role in a person's daily life, self-care activities and business life. When the flexor tendon system, which is necessary for the effective use of the hand, is damaged, it can cause physical, socioeconomic deterioration, mood disorders and permanent disabilities in the individual. Treatment of flexor tendon injuries after appropriate surgical repair ıt includes an intensive rehabilitation program. In this study, it was aimed to investigate the early rehabilitation results of patients who underwent a rehabilitation program after Zone II flexor tendon injury by comparing the improvements in joint range of motion, pain, functionality and quality of life with other zone injuries.

Conditions

  • Flexor Tendon Rupture
  • Hand Injuries
  • Rehabilitation

Interventions

OTHER

rehabilitation program

All fingers of the injured hand are fitted with a dorsal blocking orthosis. Early passive mobilization exercises in the form of passive flexion and extension and edema massage will be taught and it will be recommended to be applied every two hours during the day.

Sponsors & Collaborators

  • Kirsehir Ahi Evran Universitesi

    lead OTHER

Principal Investigators

  • Nazife K KAPAN, MD · Kırşehir Ahi Evran University, Kırşehir/TURKEY

  • Merve K KAPAN, PT · Ankara City Hospital, Ankara/TURKEY

  • Berat Meryem A ALKAN, Prof. Dr. · Ankara City Hospital, Ankara/TURKEY

  • Bedriye B BAŞKAN, Prof. Dr. · Ankara City Hospital, Ankara/TURKEY

  • Tezel YŞ YILDIRIM ŞAHAN, Assoc. Prof. · Health Sciences Univercity, Gülhane faculty of physiotherapy and rehabilitation, Ankara/TURKEY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2023-12-21
Completion
2024-01-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06112145 on ClinicalTrials.gov